|
[1]
|
Hiasa, M., Harada, T., Tanaka, E. and Abe, M. (2021) Pathogenesis and Treatment of Multiple Myeloma Bone Disease. Japanese Dental Science Review, 57, 164-173. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Danziger, S.A., McConnell, M., Gockley, J., et al. (2020) Bone Marrow Microenvironments That Contribute to Patient Outcomes in Newly Diagnosed Multiple Myeloma: A Cohort Study of Patients in the Total Therapy Clinical Trials. PLOS Medicine, 17, e1003323.
|
|
[3]
|
Schinke, C., Poos, A.M., Bauer, M., John, L., Johnson, S., Deshpande, S., et al. (2022) Characterizing the Role of the Immune Microenvironment in Multiple Myeloma Progression at a Single-Cell Level. Blood Advances, 6, 5873-5883. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Jafari, A., Fairfield, H., Andersen, T.L. and Reagan, M.R. (2021) Myeloma-Bone Marrow Adipocyte Axis in Tumour Survival and Treatment Response. British Journal of Cancer, 125, 775-777. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Beider, K., Voevoda-Dimenshtein, V., Zoabi, A., Rosenberg, E., Magen, H., Ostrovsky, O., et al. (2022) CXCL13 Chemokine Is a Novel Player in Multiple Myeloma Osteolytic Microenvironment, M2 Macrophage Polarization, and Tumor Progression. Journal of Hematology & Oncology, 15, Article No. 144. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Yip, R.K.H., Er, J., Qin, L., Nguyen, Q.H., Motyer, A., Rimes, J.S., et al. (2025) Profiling the Spatial Architecture of Multiple Myeloma in Human Bone Marrow Trephine Biopsy Specimens with Spatial Transcriptomics. Blood, 146, 1837-1849. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Hagos, Y.B., Lecat, C.S.Y., Patel, D., Mikolajczak, A., Castillo, S.P., Lyon, E.J., et al. (2024) Deep Learning Enables Spatial Mapping of the Mosaic Microenvironment of Myeloma Bone Marrow Trephine Biopsies. Cancer Research, 84, 493-508. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Lutz, R., Poos, A.M., Solé-Boldo, L., John, L., Wagner, J., Prokoph, N., et al. (2025) Bone Marrow Breakout Lesions Act as Key Sites for Tumor-Immune Cell Diversification in Multiple Myeloma. Science Immunology, 10, eadp6667. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Liu, J., Wang, C., Guo, W., Zeng, P., Liu, Y., Lang, N., et al. (2021) A Preliminary Study Using Spinal MRI-Based Radiomics to Predict High-Risk Cytogenetic Abnormalities in Multiple Myeloma. La radiologia medica, 126, 1226-1235. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Sachpekidis, C., Hajiyianni, M., Grözinger, M., Piller, M., Kopp-Schneider, A., Mai, E.K., et al. (2026) Validation of Novel Low-Dose CT Methods for Quantifying Bone Marrow in the Appendicular Skeleton of Patients with Multiple Myeloma: Initial Results from the [18F]FDG PET/CT Sub-Study of the Phase 3 GMMG-HD7 Trial. European Journal of Nuclear Medicine and Molecular Imaging, 53, 1509-1520. [Google Scholar] [CrossRef]
|
|
[11]
|
Sachpekidis, C., Enqvist, O., Ulén, J., Kopp-Schneider, A., Pan, L., Jauch, A., et al. (2023) Application of an Artificial Intelligence-Based Tool in [18F]FDG PET/CT for the Assessment of Bone Marrow Involvement in Multiple Myeloma. European Journal of Nuclear Medicine and Molecular Imaging, 50, 3697-3708. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Liu, H., Zhang, B., Chen, H., Wang, H., Qin, X., Sun, C., et al. (2025) Targeted Delivery of c(RGDfk)-Modified Liposomes to Bone Marrow through in Vivo Hitchhiking Neutrophils for Multiple Myeloma Therapy. Advanced Science, 12, Article 2409895. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Mougiakakos, D., Bach, C., Böttcher, M., Beier, F., Röhner, L., Stoll, A., et al. (2021) The IKZF1–IRF4/IRF5 Axis Controls Polarization of Myeloma-Associated Macrophages. Cancer Immunology Research, 9, 265-278. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Kamrani, S., Naseramini, R., Khani, P., Razavi, Z.S., Afkhami, H., Atashzar, M.R., et al. (2025) Mesenchymal Stromal Cells in Bone Marrow Niche of Patients with Multiple Myeloma: A Double-Edged Sword. Cancer Cell International, 25, Article No. 117. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Iannozzi, N.T., Giuliani, N. and Storti, P. (2025) Deciphering the Bone Marrow Microenvironment’s Role in Multiple Myeloma Immunotherapy Resistance. Frontiers in Immunology, 16, Article 1613265. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
de Jong, M.M.E., Kellermayer, Z., Papazian, N., Tahri, S., Hofste op Bruinink, D., Hoogenboezem, R., et al. (2021) The Multiple Myeloma Microenvironment Is Defined by an Inflammatory Stromal Cell Landscape. Nature Immunology, 22, 769-780. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
Fairfield, H., Dudakovic, A., Khatib, C.M., Farrell, M., Costa, S., Falank, C., et al. (2021) Myeloma-Modified Adipocytes Exhibit Metabolic Dysfunction and a Senescence-Associated Secretory Phenotype. Cancer Research, 81, 634-647. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
Xia, J., Zhang, J., Wu, X., Du, W., Zhu, Y., Liu, X., et al. (2022) Blocking Glycine Utilization Inhibits Multiple Myeloma Progression by Disrupting Glutathione Balance. Nature Communications, 13, Article No. 4007. [Google Scholar] [CrossRef] [PubMed]
|
|
[19]
|
Sun, J., Park, C., Guenthner, N., Gurley, S., Zhang, L., Lubben, B., et al. (2022) Tumor-Associated Macrophages in Multiple Myeloma: Advances in Biology and Therapy. Journal for ImmunoTherapy of Cancer, 10, e003975. [Google Scholar] [CrossRef] [PubMed]
|
|
[20]
|
Urdeitx, P., Mousavi, S.J., Avril, S. and Doweidar, M.H. (2023) Computational Modeling of Multiple Myeloma Interactions with Resident Bone Marrow Cells. Computers in Biology and Medicine, 153, Article 106458. [Google Scholar] [CrossRef] [PubMed]
|
|
[21]
|
Merz, M., Hu, Q., Merz, A.M.A., Wang, J., Hutson, N., Rondeau, C., et al. (2023) Spatiotemporal Assessment of Immunogenomic Heterogeneity in Multiple Myeloma. Blood Advances, 7, 718-733. [Google Scholar] [CrossRef] [PubMed]
|
|
[22]
|
Meng, Y., Yang, Y., Hu, M., Zhang, Z. and Zhou, X. (2023) Artificial Intelligence-Based Radiomics in Bone Tumors: Technical Advances and Clinical Application. Seminars in Cancer Biology, 95, 75-87. [Google Scholar] [CrossRef] [PubMed]
|
|
[23]
|
Prior, O., Macarro, C., Navarro, V., Monreal, C., Ligero, M., Garcia-Ruiz, A., et al. (2024) Identification of Precise 3D CT Radiomics for Habitat Computation by Machine Learning in Cancer. Radiology: Artificial Intelligence, 6, 12. [Google Scholar] [CrossRef] [PubMed]
|
|
[24]
|
Hong, J.H., Jung, J., Jo, A., Nam, Y., Pak, S., Lee, S., et al. (2021) Development and Validation of a Radiomics Model for Differentiating Bone Islands and Osteoblastic Bone Metastases at Abdominal CT. Radiology, 299, 626-632. [Google Scholar] [CrossRef] [PubMed]
|
|
[25]
|
Wennmann, M., Neher, P., Stanczyk, N., Kahl, K., Kächele, J., Weru, V., et al. (2023) Deep Learning for Automatic Bone Marrow Apparent Diffusion Coefficient Measurements from Whole-Body Magnetic Resonance Imaging in Patients with Multiple Myeloma: A Retrospective Multicenter Study. Investigative Radiology, 58, 273-282. [Google Scholar] [CrossRef] [PubMed]
|
|
[26]
|
Mann, D.C., Rutherford, M.W., Farmer, P., Eichhorn, J.M., Palot Manzil, F.F. and Wardell, C.P. (2025) Evaluating Skellytour for Automated Skeleton Segmentation from Whole-Body CT Images. Radiology: Artificial Intelligence, 7, e240050. [Google Scholar] [CrossRef] [PubMed]
|
|
[27]
|
Hussain, M., Khan, F. and Al Hadidi, S. (2023) The Use of Bone-Modifying Agents in Multiple Myeloma. Blood Reviews, 57, Article 100999. [Google Scholar] [CrossRef] [PubMed]
|
|
[28]
|
Leone, A., Criscuolo, M., Gullì, C., Petrosino, A., Carlo Bianco, N. and Colosimo, C. (2021) Systemic Mastocytosis Revisited with an Emphasis on Skeletal Manifestations. La radiologia medica, 126, 585-598. [Google Scholar] [CrossRef] [PubMed]
|
|
[29]
|
Giannandrea, D., Platonova, N., Colombo, M., Mazzola, M., Citro, V., Adami, R., et al. (2022) Extracellular Vesicles Mediate the Communication between Multiple Myeloma and Bone Marrow Microenvironment in a NOTCH Dependent Way. Haematologica, 107, 2183-2194. [Google Scholar] [CrossRef] [PubMed]
|
|
[30]
|
Bernstein, Z.S., Kim, E.B. and Raje, N. (2022) Bone Disease in Multiple Myeloma: Biologic and Clinical Implications. Cells, 11, Article 2308. [Google Scholar] [CrossRef] [PubMed]
|
|
[31]
|
Chakraborty, R., Hillengass, J. and Lentzsch, S. (2023) How Do We Image Patients with Multiple Myeloma and Precursor States. British Journal of Haematology, 203, 536-545. [Google Scholar] [CrossRef] [PubMed]
|
|
[32]
|
Zheng, M., Grant, F.D. and Zhuang, H. (2024) Prominent Bone Marrow Infiltration in the Appendicular Skeleton in a B-Cell Acute Lymphoblastic Leukemia Patient Demonstrated by FDG PET-MRI. Clinical Nuclear Medicine, 49, e712-e714. [Google Scholar] [CrossRef] [PubMed]
|
|
[33]
|
Paschali, A., Panagiotidis, E., Triantafyllou, T., Palaska, V., Tsirou, K., Verrou, E., et al. (2021) A Proposed Index of Diffuse Bone Marrow [18F]-FDG Uptake and PET Skeletal Patterns Correlate with Myeloma Prognostic Markers, Plasma Cell Morphology, and Response to Therapy. European Journal of Nuclear Medicine and Molecular Imaging, 48, 1487-1497. [Google Scholar] [CrossRef] [PubMed]
|
|
[34]
|
Desantis, V., Andriano, A., Düking, T., Hartwig, O., Ingravallo, G., Biondo, M., et al. (2025) Spatial Imaging Unlocks the Potential of Charting Multiple Myeloma and Extramedullary Disease. Journal of Hematology & Oncology, 18, Article No. 47. [Google Scholar] [CrossRef] [PubMed]
|
|
[35]
|
de Jong, M.M.E., Fokkema, C., Papazian, N., Czeti, Á., Appelman, M.K., Vermeulen, M., et al. (2024) An IL-1β-Driven Neutrophil-Stromal Cell Axis Fosters a Baff-Rich Protumor Microenvironment in Individuals with Multiple Myeloma. Nature Immunology, 25, 820-833. [Google Scholar] [CrossRef] [PubMed]
|
|
[36]
|
Wennmann, M., Klein, A., Bauer, F., Chmelik, J., Grözinger, M., Uhlenbrock, C., et al. (2022) Combining Deep Learning and Radiomics for Automated, Objective, Comprehensive Bone Marrow Characterization from Whole-Body MRI: A Multicentric Feasibility Study. Investigative Radiology, 57, 752-763. [Google Scholar] [CrossRef] [PubMed]
|
|
[37]
|
Musto, P., Engelhardt, M., Caers, J., Bolli, N., Kaiser, M., Van de Donk, N., et al. (2021) 2021 European Myeloma Network Review and Consensus Statement on Smoldering Multiple Myeloma: How to Distinguish (and Manage) Dr. Jekyll and Mr. Hyde. Haematologica, 106, 2799-2812. [Google Scholar] [CrossRef] [PubMed]
|
|
[38]
|
Sachpekidis, C., Enqvist, O., Ulén, J., Kopp-Schneider, A., Pan, L., Mai, E.K., et al. (2024) Artificial Intelligence-Based, Volumetric Assessment of the Bone Marrow Metabolic Activity in [18F]FDG PET/CT Predicts Survival in Multiple Myeloma. European Journal of Nuclear Medicine and Molecular Imaging, 51, 2293-2307. [Google Scholar] [CrossRef] [PubMed]
|
|
[39]
|
Roman-Trufero, M., Auner, H.W. and Edwards, C.M. (2022) Multiple Myeloma Metabolism—A Treasure Trove of Therapeutic Targets? Frontiers in Immunology, 13, Article 897862. [Google Scholar] [CrossRef] [PubMed]
|
|
[40]
|
Werner, S., Krauss, B. and Horger, M. (2022) Dual-Energy CT-Based Bone Marrow Imaging in Multiple Myeloma: Assessment of Focal Lesions in Relation to Disease Status and MRI Findings. Academic Radiology, 29, 245-254. [Google Scholar] [CrossRef] [PubMed]
|
|
[41]
|
Reinert, C.P., Krieg, E., Esser, M., Nikolaou, K., Bösmüller, H. and Horger, M. (2021) Role of Computed Tomography Texture Analysis Using Dual-Energy-Based Bone Marrow Imaging for Multiple Myeloma Characterization: Comparison with Histology and Established Serologic Parameters. European Radiology, 31, 2357-2367. [Google Scholar] [CrossRef] [PubMed]
|
|
[42]
|
Pan, Q., Luo, Y., Cao, X. and Li, J. (2021) Increased Uptake of 68Ga-Pentixafor in Thymic Rebound after Chemotherapy in a Patient with Multiple Myeloma. Clinical Nuclear Medicine, 46, 90-92. [Google Scholar] [CrossRef] [PubMed]
|
|
[43]
|
Barakat, A., Doncheva, N.T., Prado, J., Moll, L., Jensen, J.L., Díaz-delCastillo, M., et al. (2025) A Ligand-Receptor Interactome of the Bone Tumor Microenvironment in Multiple Myeloma Bone Pain. Pain, 166, 2831-2850. [Google Scholar] [CrossRef] [PubMed]
|